Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Comparison of Two Methods of Subcision Nokor and Blunt Blade in Acne Scars Treatment
Kamran Balighi
Kamran Balighi

Professor of Dermatology

Department Dermatology

School of Medicine

Razi Hospital

Tehran University of Medical Sciences

All Documents
1. Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study, Dermatology Practical and Conceptual (2025)
2. Are Sites of Primary Lesions in Pemphigus Vulgaris More Prone to Relapse?, Oral Diseases (2024)
3. Comparison of Efficacy and Safety of Tretinoin 0.05% and Glycolic Acid Peeling 70% in Axillary and Neck Lesions of Acanthosis Nigricans: A Single-Blinded, Randomized Trial, Journal of Cosmetic Dermatology (2024)
4. Investigating the Impact of Added Profhilo Mesogel to Subcision Versus Subcision Monotherapy in Treating Acne Scars; a Single-Blinded, Split-Face Randomized Trial, Journal of Cosmetic Dermatology (2024)
5. Rituximab As a Maintenance Treatment in Patients With Pemphigus Vulgaris: When Is the Right Time for Discontinuation?, Journal of Cosmetic Dermatology (2024)
6. Vitamin D and Hpv Infection: Clinical Pearls, Journal of Cosmetic Dermatology (2024)
7. A Case Report of Esophageal Cancer in a Patient With Pemphigus Vulgaris: A Coincidence or Something Beyond That?, Cancer Reports (2023)
8. Anatomic Evaluation of the Normal Variants of the Arteries of Face Using Color Doppler Ultrasonography: Implications for Facial Aesthetic Procedures, Journal of Cosmetic Dermatology (2023)
9. Association of Alternative Healthy Eating Index and Severity of Pemphigus Vulgaris: A Crosssectional Study, PLoS ONE (2023)
10. Covid Outcome in Pemphigus: Does Rituximab Make Pemphigus Patients Susceptible to More Severe Covid-19?, Journal of Cosmetic Dermatology (2023)
11. Elevated Serum Level of B-Cell Activating Factor (Baff) After Rituximab Therapy in Pemphigus Vulgaris Patients Suggests a Possible Therapeutic Efficacy of B-Cell Depletion Therapies Combined With Anti-Baff Agents, International Journal of Dermatology (2023)
12. Factors Associated With the Healing Time of Pemphigus Vulgaris Oral Lesions: A Prospective Study, Oral Diseases (2023)
13. Generalized Pustular Psoriasis Flare-Up After Both Doses of Bbibp-Corv Vaccination in a Patient Under Adalimumab Treatment: A Case Report, Case Reports in Dermatology (2023)
14. Infections in Hospitalized Patients With Psoriasis in a Skin Referral Hospital, Dermatology Practical and Conceptual (2023)
15. Isotretinoin and Timing of Procedural Interventions: Clinical Implications and Practical Points, Journal of Cosmetic Dermatology (2023)
16. Kaposi's Sarcoma in a Patient With Pemphigus Vulgaris Mimicking Exacerbation of Pemphigus, Cancer Reports (2023)
17. Nail Abnormalities in Subepidermal Blistering Diseases: A Cross-Sectional Study, International Journal of Dermatology (2023)
18. Odss Vs. Absis and Pdai Oral Parts in Pemphigus Vulgaris: Inter-Rater Reliability and Testing Times, Oral Diseases (2023)
19. Rituximab for the Treatment of Epidermolysis Bullosa Acquisita: A Large Case Series of 15 Patients, JDDG - Journal of the German Society of Dermatology (2023)
20. Rituximab Treatment and Improvement of Health-Related Quality of Life in Patients With Pemphigus, Cutis (2023)
21. Rituximab Zur Behandlung Von Epidermolysis Bullosa Acquisita: Eine Große Fallserie Mit 15 Patienten, JDDG - Journal of the German Society of Dermatology (2023)
22. Serologic Biomarkers in Pemphigus Monitoring: C-Reactive Protein, Macrophage Migration Inhibitory Factor, and Prolactin Levels Versus Autoantibody Assays, Iranian Journal of Allergy# Asthma and Immunology (2023)
23. The Impact of the Covid-19 Pandemic on the Diagnosis and Treatment of Skin Cancers, a Mini Review, Cancer Reports (2023)
24. Treatment Resistance to Tnf- Α Inhibitors in Patients With Psoriasis, Dermatologic Therapy (2023)
25. Two Asymptomatic Facial Erythematous Macules in an Adult Male, Skin Health and Disease (2023)
26. Various Aspects of the Relationship Between Vitiligo and the Covid-19 Pandemic or Sars-Cov-2 Vaccines: Clinical Pearls for Dermatologists, Journal of Cosmetic Dermatology (2023)
27. A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum, Dermatologic Therapy (2022)
28. Adverse Outcome and Severity of Covid-19 in Patients With Autoimmune Bullous Diseases: A Historical Cohort Study, Dermatologic Therapy (2022)
29. Applicability of Glucocorticoid Toxicity Index in Pemphigus: Comparison Between Two Groups of Rituximab-Treated and Rituximab-Naive Patients, Dermatologic Therapy (2022)
30. Assessment of Health-Related Quality of Life in Patients With Frontal Fibrosing Alopecia, Journal of Cosmetic Dermatology (2022)
31. Botulinum Toxin Injection As a Single or Combined Treatment With Non-Cross-Linked High Molecular Weight and Low Molecular Weight Hyaluronic Acid Gel for Neck Rejuvenation: A Randomized Clinical Trial, Dermatologic Therapy (2022)
32. Clinicopathological and Demographic Characteristics of Paget’S Disease: A 4-Year Study Showing a Male Predominance in Extra-Mammary Paget, Dermatology Practical and Conceptual (2022)
33. Coexistence of Pemphigus Vulgaris and Lichen Planus Following Covid-19 Vaccination, Case Reports in Dermatological Medicine (2022)
34. Covid Vaccination in Patients Under Treatment With Rituximab: A Presentation of Two Cases From Iran and a Review of the Current Knowledge With a Specific Focus on Pemphigus, Dermatologic Therapy (2022)
35. Covid Vaccine Recommendations in Dermatologic Patients on Immunosuppressive Agents: Lessons Learned From Pandemic, Journal of Cosmetic Dermatology (2022)
36. Covid-19 Vaccines and Filler Reactions: Should It Be Considered As a Concern?, Journal of Cosmetic Dermatology (2022)
37. Dexamethasone or Prednisone: Which One Should Be the Corticosteroid of Choice in Patients With Pemphigus Vulgaris?, Dermatologic Therapy (2022)
38. Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients, Case Reports in Dermatology (2022)
39. Does the Mode of Delivery Impact Atopic Dermatitis Severity in Children?, European Journal of Pediatric Dermatology (2022)
40. Dramatic Resolution of Cutaneous Lymphoid Hyperplasia After Receiving Intravenous Immunoglobulin for Covid-19, Dermatologic Therapy (2022)
41. Efficacy and Safety of Oral Pioglitazone in the Management of Lichen Planopilaris in Comparison With Clobetasol: A Randomized Clinical Trial, Dermatologic Therapy (2022)
42. Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran, Dermatologic Therapy (2022)
43. Evaluating the Risk-To-Benefit Ratio of Using Cotrimoxazole As a Pneumocystis Pneumonia Preventative Intervention Among Pemphigus Patients Treated With Rituximab: A Retrospective Study With 494 Patients, Dermatologic Therapy (2022)
44. Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?, Frontiers in Medicine (2022)
45. Multiple Cycles of Rituximab Therapy for Pemphigus: A Group of Patients With Difficult- To-Treat Disease or a Consequence of Late Rituximab Initiation?, Dermatologic Therapy (2022)
46. Pemphigus Patients With Initial Negative Levels of Anti-Desmoglein: A Subtype With Different Profile?, Dermatologic Therapy (2022)
47. Pregnancy Outcomes in Women With Pemphigus Exposed to Rituximab Before or During Pregnancy, International Journal of Women's Dermatology (2022)
48. Prevalence and Management of Chronic Hepatitis B in Pemphigus and Pemphigoid Patients: New Evidence for the Safety of Rituximab, Dermatologic Therapy (2022)
49. Retrospective Study of Gingival Involvement in Pemphigus: A Difficult to Treat Phenomenon, Dermatologic Therapy (2022)
50. Rituximab Monotherapy in Mild Pemphigus, Journal of Dermatological Treatment (2022)
51. Sars-Cov-2 Vaccination and Practical Points in Psoriasis Patients: A Narrative Review, Dermatologic Therapy (2022)
52. Serious Health Threat of Mucormycosis During the Ongoing Covid-19 Pandemic: What Dermatologists Need to Know in This Regard, International Journal of Dermatology (2022)
53. Stigma Experience in Patients With Vitiligo: A Comprehensive Study in a Skin Hospital, Acta Medica Iranica (2022)
54. The Efficacy of Rituximab in Patients With Mucous Membrane Pemphigoid, Journal of Dermatological Treatment (2022)
55. The Role of Sars-Cov-2 Infection and Its Vaccines in Various Types of Hair Loss, Dermatologic Therapy (2022)
56. A Systematic Review on Efficacy, Safety, and Treatment-Durability of Low-Dose Rituximab for the Treatment of Pemphigus: Special Focus on Covid-19 Pandemic Concerns, Immunopharmacology and Immunotoxicology (2021)
57. Characteristics and Outcomes of Covid-19 in Patients With Autoimmune Bullous Diseases: A Retrospective Cohort Study, Journal of the American Academy of Dermatology (2021)
58. Co-Occurrence of Dowling–Degos Disease and Pemphigus Vulgaris, International Journal of Dermatology (2021)
59. Correlation of Anti-Γ/Ε Nicotinic Acetylcholine Receptor Antibody Levels With Anti-Desmoglein 1,3 Antibody Levels and Disease Severity in Pemphigus Vulgaris, Clinical and Experimental Dermatology (2021)
60. Covid-19 Infection Risk in Patients on Immunosuppressive/Immunomodulator Therapy: A Single Center Study, Dermatologic Therapy (2021)
61. Does Double-Pass Pulsed-Dye Laser With Long and Short Pulse Duration Increase Treatment Efficacy of Port-Wine Stain? a Randomized Clinical Trial, Dermatologic Surgery (2021)
62. Efficacy and Safety of Biosimilar Rituximab in Patients With Pemphigus Vulgaris: A Prospective Observational Study, Journal of Dermatological Treatment (2021)
63. Epidermolysis Bullosa Acquisita: The Most Frequent Pemphigoid Disease in Patients With Dermal Binding Autoantibodies by Indirect Immunofluorescence Microscopy on Human Salt-Split Skin in Tehran, Iran, Journal of the European Academy of Dermatology and Venereology (2021)
64. Lichen Planus-Like Lesions in 36 Patients With Pemphigus: A Cross-Sectional Study, Oral Diseases (2021)
65. Old World Cutaneous Leishmaniasis in Iran: Clinical Variants and Treatments, Journal of Dermatological Treatment (2021)
66. Osteonecrosis of the Jaw in a Pemphigus Vulgaris Patient Induced by Long-Term Use of Bisphosphonates: A Case Report and Review of the Literature, Dermatologic Therapy (2021)
67. Rituximab Exhibits a Better Safety Profile When Used As a First Line of Treatment for Pemphigus Vulgaris: A Retrospective Study, International Immunopharmacology (2021)
68. Rituximab in Practice: Clinical Evaluation of Patients With Pemphigus After Rituximab Administration, Dermatologic Therapy (2021)
69. Autoimmune Bullous Disease Quality of Life (Abqol) Questionnaire: Validation of the Translated Persian Version in Pemphigus Vulgaris, International Journal of Women's Dermatology (2020)
70. Concomitant Bullous Pemphigoid and Palmoplantar Keratoderma: A Report of Three Cases and Review of Literature, Dermatologic Therapy (2020)
71. Cosmetic Surgeries Amidst Pandemic Area of Covid-19: Suggested Protocol, Journal of Dermatological Treatment (2020)
72. Diagnostic Value of Cytology in Oral Ulcer and Comparison With Histopathology and Direct Immunofluorescence, Dermatologic Therapy (2020)
73. Estimated Cut-Off Values for Pemphigus Severity Classification According to Pemphigus Disease Area Index (Pdai), Autoimmune Bullous Skin Disorder Intensity Score (Absis), and Anti-Desmoglein 1 Autoantibodies, BMC Dermatology (2020)
74. Family Impact of Pemphigus Disease in an Iranian Population Using the Family Dermatology Life Quality Index, International Journal of Women's Dermatology (2020)
75. Granuloma Annulare After Botulonium Toxin a Injection: A Rare Association, Journal of Cosmetic Dermatology (2020)
76. Immunohistochemical Staining in the Assessment of Melanoma Tumor Thickness, Pathology and Oncology Research (2020)
77. Intralesional Injection of Biosimilar Rituximab in Recalcitrant Mucocutaneous Lesions of Patients With Pemphigus Vulgaris: A Pilot Study, Dermatologic Therapy (2020)
78. Investigating Expression Pattern of Eight Immune-Related Genes in Pemphigus Patients Compared With the Healthy Controls and After Rituximab Therapy: Potential Roles of Ctla4 and Fcgr3a Genes Expression in Outcomes of Rituximab Therapy, Dermatologic Therapy (2020)
79. Paradoxical Reaction to Rituximab in Patients With Pemphigus: A Report of 10 Cases, Immunopharmacology and Immunotoxicology (2020)
80. Pathogenic and Protective Roles of Cytokines in Pemphigus: A Systematic Review, Cytokine (2020)
81. Rituximab in Childhood and Juvenile Autoimmune Bullous Diseases As First-Line and Second-Line Treatment: A Case Series of 13 Patients, Journal of Dermatological Treatment (2020)
82. Self-Limited Acne Agminate-Like Granulomatous Reaction to Facial Laser Rejuvenation in a Patient With Comedonal Acne Vulgaris, Journal of Cosmetic and Laser Therapy (2020)
83. Single-Nucleotide Polymorphisms Associated With Pemphigus Vulgaris: Potent Markers for Better Treatment and Personalized Medicine, International Journal of Immunogenetics (2020)
84. Switching From Pemphigus Vulgaris to Psoriasis: A Rare Report of Three Cases, International Journal of Dermatology (2020)
85. Transition Between Pemphigus Vulgaris and Pemphigus Foliaceus: A 10-Year Follow-Up Study, JDDG - Journal of the German Society of Dermatology (2020)
86. Angina Bullosa Haemorrhagica-Like Lesions in Pemphigus Vulgaris, Australasian Journal of Dermatology (2019)
87. Candidate Predisposition Variants in Kaposi Sarcoma As Detected by Whole-Genome Sequencing, Open Forum Infectious Diseases (2019)
88. Comparing Early and Late Treatments With Rituximab in Pemphigus Vulgaris: Which One Is Better?, Archives of Dermatological Research (2019)
89. Comparing the Short-Term Therapeutic Effects and Safety Profiles of Rituximab Therapy in Pemphigus Vulgaris Patients Either Early Treated or Later Than Six Months, Journal of Dermatological Treatment (2019)
90. Effects of L-Carnitine Supplementation on Cardiovascular and Bone Turnover Markers in Patients With Pemphigus Vulgaris Under Corticosteroids Treatment: A Randomized, Double-Blind, Controlled Trial, Dermatologic Therapy (2019)
91. Effects of L-Carnitine Supplementation on Cardiovascular and Bone Turnover Markers in Patients With Pemphigus Vulgaris Under Corticosteroids Treatment: A Randomized, Double-Blind, Controlled Trial, Dermatologic Therapy (2019)
92. Iranian Guideline for Rituximab Therapy in Pemphigus Patients, Dermatologic Therapy (2019)
93. Lichen Planopilaris: Retrospective Study on the Characteristics and Treatment of 291 Patients, Journal of Dermatological Treatment (2019)
94. Reply To: “Comment on ‘Trichloroacetic Acid As a Treatment for Persistent Oral Mucosal Lesions in Pemphigus Vulgaris'”, Journal of the American Academy of Dermatology (2019)
95. Short-Term Clinical and Serological Follow-Up With Conventional and Conformational Anti-Desmoglein Antibodies in Treatment-Naive and Previously Treated Patients With Pemphigus Vulgaris After Receiving Rituximab, International Journal of Women's Dermatology (2019)
96. Trichloroacetic Acid As a Treatment for Persistent Oral Mucosal Lesions in Pemphigus Vulgaris, Journal of the American Academy of Dermatology (2019)
97. Unexpected Worsening of Pemphigus Vulgaris After Rituximab: A Report of Three Cases, International Immunopharmacology (2019)
98. “Change Over Time in the Treatment of Pemphigus Vulgaris Between 2004 and 2016 in Iran”: A Multiple Cross-Sectional Study, Dermatologic Therapy (2019)
99. Anti-Desmoglein-1 Levels As Predictor of Prednisolone Tapering in Pemphigus Vulgaris Patients Treated With Rituximab, Dermatologic Therapy (2018)
100. Bpdai and Absis Correlate With Serum Anti-Bp180 Nc16a Igg But Not With Anti-Bp230 Igg in Patients With Bullous Pemphigoid, Archives of Dermatological Research (2018)
101. Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran, Acta Medica Iranica (2018)
102. Coexistence of Oral Lichen Planus and Pemphigus Vulgaris, Clinical Oral Investigations (2018)
103. Comparison of Ethylenediaminetetraacetic Acid-Treated Desmoglein Elisa and Conventional Desmoglein Elisa in the Evaluation of Pemphigus Vulgaris in Remission, Journal of the American Academy of Dermatology (2018)
104. Sixteen-Year History of Rituximab Therapy for 1085 Pemphigus Vulgaris Patients: A Systematic Review, International Immunopharmacology (2018)
105. Treatment of Basal Cell Carcinoma: Is Intralesional Methotrexate an Option?, Journal of Dermatological Treatment (2018)
106. A Case Report of Paraneoplastic Pemphigus Associated With Retroperitoneal Inflammatory Myofibroblastic Tumor, Acta Medica Iranica (2017)
107. Adverse Reactions Associated With Intravenous Immunoglobulin Therapy in Patients With Dermatologic Diseases: An 11-Year Retrospective Study, Iranian Journal of Dermatology (2017)
108. Anagen Hair Loss, Anti-Desmoglein 1, and Pemphigus Disease Area Index: A Signifi Cant Relationship?; [Anagener Haarverlust, Anti-Desmoglein 1 Und Pemphigus Disease Area Index: Ein Signifi Kanter Zusammenhang?], JDDG - Journal of the German Society of Dermatology (2017)
109. Cheilitis in Acne Vulgaris Patients With No Previous Use of Systemic Retinoid Products, Australasian Journal of Dermatology (2017)
110. Erythema Elevatum Diutinum Presenting With Palmoplantar Keratoderma, Clinical and Experimental Dermatology (2017)
111. Hydrocortisone 1% Cream and Sertaconazole 2% Cream to Treat Facial Seborrheic Dermatitis: A Double-Blind, Randomized Clinical Trial, International Journal of Women's Dermatology (2017)
112. Neurological Diseases and Bullous Pemphigoid: A Case-Control Study in Iranian Patients, Indian Journal of Dermatology# Venereology and Leprology (2017)
113. Rituximab Administration in a Patient With Pemphigus Vulgaris Following Reactivation of Occult Hepatitis B Virus Infection, Dermatology Online Journal (2017)
114. Segmental Pigmentation Disorder: A Rare Form of Cutaneous Dyspigmentation, Caspian Journal of Internal Medicine (2017)
115. Assessment of the Therapeutic Aspect of Systemic Non-Biologic Anti-Psoriatic Treatment Modalities Used in Combination With Methotrexate, Indian Journal of Dermatology (2016)
116. Changes in Body Mass Index and Lipid Profile in Psoriatic Patients After Treatment With Standard Protocol of Infliximab, Acta Medica Iranica (2016)
117. Evaluation of Narrow Band Uvb Therapeutic Effect on Chronic Mucocutaneous Graft Versus Host Disease Lesions: A Case Series, Iranian Journal of Dermatology (2016)
118. Immunologic Prediction of Relapse in Patients With Pemphigus Vulgaris (Pv) in Clinical Remission, Journal of the American Academy of Dermatology (2016)
119. Koebner Phenomenon in Pemphigus Vulgaris Patients, JAAD Case Reports (2016)
120. Longitudinal Melanonychia in an Iranian Population: A Study of 96 Patients, International Journal of Women's Dermatology (2016)
121. Temporal Course of Avascular Femoral Head Necrosis in Patients With Pemphigus Vulgaris; [Zeitlicher Verlauf Der Avaskularen Nekrose Des Huftkopfes Bei Patienten Mit Pemphigus Vulgaris], JDDG - Journal of the German Society of Dermatology (2016)
122. The Dual Nature of Retinoic Acid in Pemphigus and Its Therapeutic Potential: Special Focus on All-Trans Retinoic Acid, International Immunopharmacology (2016)
123. The Study of Psychiatric Comorbidity in Patient With Pemphigus, Tehran University Medical Journal (2016)
124. Trauma-Induced Pemphigus: A Case Series of 36 Patients; [Trauma-Induzierter Pemphigus: Eine Fallserie Von 36 Patienten], JDDG - Journal of the German Society of Dermatology (2016)
125. Bullous Lesions on a Chronic Cutaneous Plaque, Clinical Cases in Autoimmune Blistering Diseases (2015)
126. Rituximab Therapy Improves Recalcitrant Pemphigus Vulgaris, EXCLI Journal (2015)